KRIYA Trademark

Trademark Overview


On Friday, February 18, 2022, a trademark application was filed for KRIYA with the United States Patent and Trademark Office. The USPTO has given the KRIYA trademark a serial number of 97274557. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, October 31, 2024. This trademark is owned by Kriya Therapeutics, Inc. The KRIYA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; biochemical preparations for use in medical industry, namely, biochemical preparations for the treatment of ophthalmic-related diseases

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders
kriya

General Information


Serial Number97274557
Word MarkKRIYA
Filing DateFriday, February 18, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, October 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; biochemical preparations for use in medical industry, namely, biochemical preparations for the treatment of ophthalmic-related diseases
Goods and ServicesTesting, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 24, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 24, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKriya Therapeutics, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560

Party NameKriya Therapeutics, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306

Trademark Events


Event DateEvent Description
Tuesday, February 22, 2022NEW APPLICATION ENTERED
Thursday, February 24, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 26, 2022ASSIGNED TO EXAMINER
Monday, August 1, 2022NON-FINAL ACTION WRITTEN
Monday, August 1, 2022NON-FINAL ACTION E-MAILED
Monday, August 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 1, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 1, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 1, 2023ASSIGNED TO EXAMINER
Thursday, February 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, February 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 10, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, November 9, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 9, 2023SOU EXTENSION 1 FILED
Thursday, November 9, 2023SOU EXTENSION 1 GRANTED
Saturday, November 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 1, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, May 9, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 3, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 29, 2024SOU EXTENSION 2 FILED
Monday, April 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 29, 2024SOU EXTENSION 2 GRANTED
Wednesday, April 3, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2024SOU EXTENSION 3 FILED
Thursday, October 31, 2024SOU EXTENSION 3 GRANTED